CUREVAC N V's ticker is CVAC and the CUSIP is N2451R105. A total of 88 filers reported holding CUREVAC N V in Q2 2023. The put-call ratio across all filers is 0.60 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,037,887 | -60.6% | 298,373 | -39.9% | 0.00% | -100.0% |
| Q2 2023 | $5,175,604 | +193.7% | 496,699 | +96.5% | 0.00% | – |
| Q1 2023 | $1,761,939 | +119.2% | 252,789 | +89.6% | 0.00% | – |
| Q4 2022 | $803,799 | -66.3% | 133,300 | -56.0% | 0.00% | – |
| Q3 2022 | $2,386,000 | -72.8% | 302,801 | -53.1% | 0.00% | -100.0% |
| Q2 2022 | $8,780,000 | -38.2% | 645,147 | -10.9% | 0.00% | +50.0% |
| Q1 2022 | $14,204,000 | -76.8% | 724,269 | -59.4% | 0.00% | 0.0% |
| Q4 2021 | $61,268,000 | +16.2% | 1,785,666 | +85.0% | 0.00% | -71.4% |
| Q3 2021 | $52,725,000 | -60.2% | 965,304 | -46.5% | 0.01% | -61.1% |
| Q2 2021 | $132,514,000 | +30.5% | 1,803,399 | +62.4% | 0.02% | +5.9% |
| Q1 2021 | $101,579,000 | +24.0% | 1,110,638 | +9.9% | 0.02% | +142.9% |
| Q4 2020 | $81,922,000 | +248.4% | 1,010,494 | +100.0% | 0.01% | +40.0% |
| Q3 2020 | $23,515,000 | – | 505,136 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,625,943 | $11,332,823 | 10.01% |
| RA Capital Management | 12,245,955 | $85,354,306 | 1.93% |
| Avidity Partners Management LP | 3,550,000 | $24,743,500 | 0.82% |
| Camber Capital Management LP | 1,250,000 | $8,713 | 0.27% |
| Ghisallo Capital Management LLC | 100,000 | $697,000 | 0.17% |
| FOX RUN MANAGEMENT, L.L.C. | 31,278 | $218,008 | 0.07% |
| Alyeska Investment Group, L.P. | 1,060,382 | $7,390,863 | 0.06% |
| Green Alpha Advisors, LLC | 12,351 | $86,086 | 0.06% |
| Virtus ETF Advisers LLC | 14,114 | $98,375 | 0.05% |
| Quantamental Technologies LLC | 11,146 | $77,688 | 0.04% |